REMINDER: Our user survey closes on Friday, please submit your responses here.
What annoys me more is they have sat on that data fir weeks and let the SP drop, if they had of done this weeks ago it would have been much less of a drop or problem, they have let the doubts set in them gave that poor presentation.
I’m a new investor here, have we had final patient dosed per the 100 clinical trial as of yet? If not we could be 2 months away before and data from this trial?
https://twitter.com/proactive_uk/status/1381530543863517185?s=21
Brrr I was just thinking befit you posted that if they no it is 100% watertight then maybe Synairgen are letting them collect data on those behalf.
So fits with what your saying they do trials patients adds more to Synairgen then hit them with IP RIGHTS.
My one down side to this would be surely the MP in France couple of weeks ago is not that stupid??
I mean I’m no expert on IP’S but I can’t claim a drug just by producing a paper on something without having actually nothing to do with interferon study’s or trials in the first place.
French I never like or Trust them!!!!
My issue is say for instance coke has a patent on their formula which they do I imagine and they also had a patent on delivery of that drink via a can (which obviously they don’t but let’s say they did) surely if coke knew another company was trialling this they would be straight on to their lawyers to stop the production in its tracks before it even gets started so why are Synairgen not doing this?
Maybe I’m naive and I definitely don’t know enough but it’s just my very limited knowledge?
gggg again I’ve just had a quick glance through that document, what I don’t get is why the french are trialling 1B by nebuliser if they can’t use it? Is it like sharemead has said if they do want to commercialise it they will have to pay Synairgen royalties?